Protein Instability in Poly(Lactic-co-Glycolic Acid) Microparticles

In this review the current knowledge of protein degradation during preparation, storage and release from poly(lactic-co-glycolic acid) (PLGA) microparticles is described, as well as stabilization approaches. Although we have focussed on PLGA microparticles, the degradation processes and mechanisms described here are valid for many other polymeric release systems. Optimized process conditions as well as stabilizing excipients need to be used to counteract several stress factors that compromise the integrity of protein structure during preparation, storage, and release. The use of various stabilization approaches has rendered some success in increasing protein stability, but, still, full preservation of the native protein structure remains a major challenge in the formulation of protein-loaded PLGA microparticles.

[1]  R. Langer,et al.  Improved immunogenicity of a core-coated tetanus toxoid delivery system. , 1999, Vaccine.

[2]  K. Johnston,et al.  Encapsulation of lysozyme in a biodegradable polymer by precipitation with a vapor-over-liquid antisolvent. , 1999, Journal of pharmaceutical sciences.

[3]  S. Schwendeman,et al.  Influence of basic salts on stability and release of proteins in injectable poly(lactide-co-glycolide) delivery devices , 1999 .

[4]  T. Burke,et al.  The Acidic Microclimate in Poly(lactide-co-glycolide) Microspheres Stabilizes Camptothecins , 1999, Pharmaceutical Research.

[5]  B. Gander,et al.  Quality improvement of spray-dried, protein-loaded D,L-PLA microspheres by appropriate polymer solvent selection. , 1995, Journal of microencapsulation.

[6]  B. Gander,et al.  Diphtheria and tetanus toxoid microencapsulation into conventional and end-group alkylated PLA/PLGAs. , 1999, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[7]  R. Mehta,et al.  Adsorption of peptides to poly(D,L-lactide-co-glycolide): 1. Effect of physical factors on the adsorption , 1996 .

[8]  A. Klibanov,et al.  Can conformational changes be responsible for solvent and excipient effects on the catalytic behavior of subtilisin Carlsberg in organic solvents? , 1997, Biotechnology and bioengineering.

[9]  D. Pettit,et al.  Biodegradable polymers for protein and peptide drug delivery. , 1995, Bioconjugate chemistry.

[10]  C. Jones,et al.  Physicochemical and immunological studies on the stability of free and microsphere-encapsulated tetanus toxoid in vitro. , 1996, Vaccine.

[11]  R. Gupta,et al.  Biodegradable microspheres as controlled-release tetanus toxoid delivery systems. , 1994, Vaccine.

[12]  T. Uchida,et al.  Microencapsulation of Hepatitis B Core Antigen for Vaccine Preparation , 1998, Pharmaceutical Research.

[13]  P. G. Shao,et al.  Porcine Insulin Biodegradable Polyester Microspheres: Stability and In Vitro Release Characteristics , 2000, Pharmaceutical development and technology.

[14]  B. Gander,et al.  Improving Stability and Release Kinetics of Microencapsulated Tetanus Toxoid by Co-Encapsulation of Additives , 1998, Pharmaceutical Research.

[15]  P. Riesz,et al.  Free radical formation induced by ultrasound and its biological implications. , 1992, Free radical biology & medicine.

[16]  H. Sah Protein behavior at the water/methylene chloride interface. , 1999, Journal of pharmaceutical sciences.

[17]  J L Cleland,et al.  Development of a single-shot subunit vaccine for HIV-1. , 1997, AIDS research and human retroviruses.

[18]  R. Tilton,et al.  Adsorption of serum albumin to thin films of poly(lactide-co-glycolide). , 1999, Journal of controlled release : official journal of the Controlled Release Society.

[19]  M. Alonso,et al.  Formulation of L-asparaginase-loaded poly(lactide-co-glycolide) nanoparticles: influence of polymer properties on enzyme loading, activity and in vitro release. , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[20]  María J. Alonso,et al.  Development and characterization of protein-loaded poly(lactide-co-glycolide) nanospheres , 1997 .

[21]  E. Topp,et al.  Solid-state chemical stability of proteins and peptides. , 1999, Journal of pharmaceutical sciences.

[22]  T. Park,et al.  Protein release from poly(lactic-co-glycolic acid) microspheres: protein stability problems. , 1995, PDA journal of pharmaceutical science and technology.

[23]  J. Cleland Solvent Evaporation Processes for the Production of Controlled Release Biodegradable Microsphere Formulations for Therapeutics and Vaccines , 1998, Biotechnology progress.

[24]  R. K. Rana,et al.  Release of Human Serum Albumin from Poly(lactide-co-glycolide) Microspheres , 1990, Pharmaceutical Research.

[25]  A. Domb,et al.  Chemical Interactions Between Drugs Containing Reactive Amines with Hydrolyzable Insoluble Biopolymers in Aqueous Solutions , 1994, Pharmaceutical Research.

[26]  T. Park,et al.  Stability and release of bovine serum albumin encapsulated within poly(d,l-lactide-co-glycolide) microparticles , 1996 .

[27]  T. Park,et al.  A new preparation method for protein loaded poly(D, L-lactic-co-glycolic acid) microspheres and protein release mechanism study. , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[28]  J. Pedraz,et al.  Influence of formulation variables on the in-vitro release of albumin from biodegradable microparticulate systems. , 1997, Journal of microencapsulation.

[29]  Brooks M. Boyd,et al.  The Stability of Recombinant Human Growth Hormone in Poly(lactic-co-glycolic acid) (PLGA) Microspheres , 1997, Pharmaceutical Research.

[30]  T. Park,et al.  Microencapsulation of human growth hormone within biodegradable polyester microspheres: protein aggregation stability and incomplete release mechanism. , 1999, Biotechnology and bioengineering.

[31]  Michael J. Pikal,et al.  Rational Design of Stable Lyophilized Protein Formulations: Some Practical Advice , 1997, Pharmaceutical Research.

[32]  K. N. Dollman,et al.  - 1 , 1743 .

[33]  A. Coombes,et al.  The distribution of protein associated with poly(DL-lactide co-glycolide) microparticles and its degradation in simulated body fluids. , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[34]  A. Klibanov,et al.  Solid-phase aggregation of proteins under pharmaceutically relevant conditions. , 1994, Journal of pharmaceutical sciences.

[35]  A. Klibanov,et al.  Structure of lysozyme dissolved in neat organic solvents as assessed by NMR and CD spectroscopies. , 1999, Biotechnology and bioengineering.

[36]  C Vigneron,et al.  Preparation and characterization of protein C-loaded PLA nanoparticles. , 1999, Journal of controlled release : official journal of the Controlled Release Society.

[37]  J. Cleland,et al.  The Stabilization and Encapsulation of Human Growth Hormone into Biodegradable Microspheres , 1997, Pharmaceutical Research.

[38]  M A Tracy,et al.  Development and Scale‐up of a Microsphere Protein Delivery System , 1998, Biotechnology progress.

[39]  J. Carpenter,et al.  Use of infrared spectroscopy to assess secondary structure of human growth hormone within biodegradable microspheres. , 1999, Journal of pharmaceutical sciences.

[40]  Gerhard Winter,et al.  Microencapsulation of rh-erythropoietin, using biodegradable poly(d,l-lactide-co-glycolide): protein stability and the effects of stabilizing excipients , 1997 .

[41]  C. M. Agrawal,et al.  Technique to control pH in vicinity of biodegrading PLA-PGA implants. , 1997, Journal of biomedical materials research.

[42]  T. Park,et al.  Protein delivery from poly(lactic-co-glycolic acid) biodegradable microspheres: release kinetics and stability issues. , 1998, Journal of microencapsulation.

[43]  J. Cleland,et al.  Factors affecting the in vitro release of recombinant human interferon‐γ (rhIFN‐γ) from PLGA microspheres , 1997 .

[44]  Brooks M. Boyd,et al.  Recombinant human growth hormone poly(lactic-co-glycolic acid) (PLGA) microspheres provide a long lasting effect , 1997 .

[45]  Alexander M. Klibanov,et al.  On Protein Denaturation in Aqueous−Organic Mixtures but Not in Pure Organic Solvents , 1996 .

[46]  K. Griebenow,et al.  Structure‐guided Encapsulation of Bovine Serum Albumin in Poly(DL‐lactic‐co‐glycolic) Acid , 1998 .

[47]  M. Morlock,et al.  Recombinant human erythropoietin (rhEPO) loaded poly(lactide-co-glycolide) microspheres: influence of the encapsulation technique and polymer purity on microsphere characteristics. , 1998, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[48]  J. Benoit,et al.  NGF release from poly(D,L-lactide-co-glycolide) microspheres. Effect of some formulation parameters on encapsulated NGF stability. , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[49]  M Morlock,et al.  Erythropoietin loaded microspheres prepared from biodegradable LPLG-PEO-LPLG triblock copolymers: protein stabilization and in-vitro release properties. , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[50]  Smadar Cohen,et al.  Characterization of PLGA microspheres for the controlled delivery of IL-1α for tumor immunotherapy , 1997 .

[51]  M. Alonso,et al.  New strategies for the microencapsulation of tetanus vaccine. , 1998, Journal of microencapsulation.

[52]  A. Jones,et al.  Stable formulations of recombinant human growth hormone and interferon-gamma for microencapsulation in biodegradable microspheres. , 1996, Pharmaceutical research.

[53]  R. Mashelkar,et al.  Preparation of non-porous microspheres with high entrapment efficiency of proteins by a (water-in-oil)-in-oil emulsion technique. , 1999, Journal of controlled release : official journal of the Controlled Release Society.

[54]  T. Kissel,et al.  Monitoring Microviscosity and Microacidity of the Albumin Microenvironment Inside Degrading Microparticles from Poly(lactide-co-glycolide) (PLG) or ABA-triblock Polymers Containing Hydrophobic Poly(lactide-co-glycolide) A Blocks and Hydrophilic Poly(ethyleneoxide) B Blocks , 1998, Pharmaceutical Research.

[55]  R. Heeren,et al.  Lysozyme distribution and conformation in a biodegradable polymer matrix as determined by FTIR techniques. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[56]  P. G. Shao,et al.  Stabilization of pH-induced degradation of porcine insulin in biodegradable polyester microspheres. , 1999, Pharmaceutical development and technology.

[57]  Tae Gwan Park,et al.  Importance of in vitro experimental conditions on protein release kinetics, stability and polymer degradation in protein encapsulated poly (d,l-lactic acid-co-glycolic acid) microspheres , 1995 .

[58]  B. Gander,et al.  Physico-chemical and antigenic properties of tetanus and diphtheria toxoids and steps towards improved stability. , 1998, Biochimica et biophysica acta.

[59]  M. Alonso,et al.  Formulation strategies for the stabilization of tetanus toxoid in poly(lactide-co-glycolide) microspheres. , 1999, International journal of pharmaceutics.

[60]  S. Schwendeman,et al.  Stabilization of proteins encapsulated in injectable poly (lactide-co-glycolide) , 2000, Nature Biotechnology.

[61]  X. Wu,et al.  A novel approach to stabilization of protein drugs in poly(lactic-co-glycolic acid) microspheres using agarose hydrogel , 1998 .

[62]  J. Cleland,et al.  Stable Formulations of Recombinant Human Growth Hormone and Interferon-γ for Microencapsulation in Biodegradable Mircospheres , 1996, Pharmaceutical Research.

[63]  R. Jerome,et al.  Polylactide Microparticles Prepared by Double Emulsion-Evaporation: II. Effect of the Poly(Lactide-co-Glycolide) Composition on the Stability of the Primary and Secondary Emulsions , 1995 .

[64]  K. Suslick,et al.  The sonochemical hot spot , 1987 .

[65]  M. Schimpf,et al.  Bioerodible polymers for delivery of macromolecules , 1990 .

[66]  P. Steerenberg,et al.  Targeting pathophysiological rhythms: prednisone chronotherapy shows sustained efficacy in rheumatoid arthritis. , 2010, Annals of the rheumatic diseases.

[67]  H. Sah A new strategy to determine the actual protein content of poly(lactide-co-glycolide) microspheres. , 1997, Journal of pharmaceutical sciences.

[68]  K. Mäder,et al.  pH and Osmotic Pressure Inside Biodegradable Microspheres During Erosion1 , 1999, Pharmaceutical Research.

[69]  A. Shahzamani,et al.  A month–long effect from a single injection of microencapsulated human growth hormone , 1996, Nature Medicine.

[70]  R. Mehta,et al.  Adsorption of peptides to poly(D,L-lactide-co-glycolide): 2. Effect of solution properties on the adsorption , 1996 .

[71]  S. Schwendeman,et al.  Stabilization of bovine serum albumin encapsulated in injectable poly(lactide-co-glycolide) millicylinders) , 1998 .

[72]  T. Kissel,et al.  Ultrasonic atomization for spray drying: a versatile technique for the preparation of protein loaded biodegradable microspheres. , 1999, Journal of microencapsulation.

[73]  A. Klibanov,et al.  FTIR characterization of the secondary structure of proteins encapsulated within PLGA microspheres. , 1999, Journal of controlled release : official journal of the Controlled Release Society.

[74]  P. Morrissey,et al.  Characterization of Poly(glycolide-co-D,L-lactide)/Poly(D,L-lactide) Microspheres for Controlled Release of GM-CSF , 1997, Pharmaceutical Research.

[75]  H. Sah Protein instability toward organic solvent/water emulsification: implications for protein microencapsulation into microspheres. , 1999, PDA journal of pharmaceutical science and technology.

[76]  J. Park,et al.  Double-walled microparticles for single shot vaccine , 1997 .

[77]  J. Mcginity,et al.  Selection of the solvent system for the preparation of poly(d,l-lactic-co-glycolic acid) microspheres containing tumor necrosis factor-alpha (TNF-α) , 1998 .

[78]  J L Cleland,et al.  The development of stable protein formulations: a close look at protein aggregation, deamidation, and oxidation. , 1993, Critical reviews in therapeutic drug carrier systems.

[79]  S. Sharif,et al.  A comparison of alternative methods for the determination of the levels of proteins entrapped in poly(lactide-co-glycolide) microparticles , 1995 .

[80]  W Wang,et al.  Instability, stabilization, and formulation of liquid protein pharmaceuticals. , 1999, International journal of pharmaceutics.

[81]  J. Pedraz,et al.  Stability of BSA encapsulated into PLGA microspheres using PAGE and capillary electrophoresis , 1998 .

[82]  J. Benoit,et al.  Why Does PEG 400 Co-Encapsulation Improve NGF Stability and Release from PLGA Biodegradable Microspheres? , 1999, Pharmaceutical Research.

[83]  M. Manning,et al.  Controlled release of ionic compounds from poly (l-lactide) microspheres produced by precipitation with a compressed antisolvent , 1997 .

[84]  H. Sah,et al.  The influence of biodegradable microcapsule formulations on the controlled release of a protein , 1994 .

[85]  H. Sah Stabilization of proteins against methylene chloride/water interface-induced denaturation and aggregation. , 1999, Journal of controlled release : official journal of the Controlled Release Society.

[86]  Chung C. Hsu,et al.  On the structural preservation of recombinant human growth hormone in a dried film of a synthetic biodegradable polymer. , 1999, Journal of pharmaceutical sciences.

[87]  D. Rose PROTEIN STABILITY PROBLEMS. , 1965, Journal of dairy science.